Latest News on Sun Pharmaceutical Industries
Showing of 0 - 10 from 11 results
Sun Pharmaceutical Industries - Total results - 11
-
Dec 04, 2018
Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi
Dilip Shanghvi, founder and managing director of Sun Pharma said the company will work towards re-establishing credibility and corporate governance -
Jun 13, 2018
Sun Pharma shares gain 4% after USFDA clears drug major; market cap rises by Rs 2,384 cr
Shares of Sun Pharmaceutical Industries on Wednesday gained nearly 4 percent after the company received establishment inspection report (EIR) from the US health regulator for its Halol facility in Gujarat -
Jun 13, 2018
Sun Pharma receives EIR for its crucial Halol plant in Gujarat, US health regulator clears drug major
Sun Pharmaceutical Industries said it has received establishment inspection report (EIR) from US health regulator for its Halol facility in Gujarat -
Nov 15, 2017
Sun Pharma shares drop over 3% on disappointing earnings in Jul-Sep quarter
Sun Pharma's consolidated total revenue from operations stood at Rs 6,650.34 crore -
Jun 08, 2016
Sun Pharma forays into dermatology segment by launching sunscreen brand Suncros
The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product -
May 13, 2015
Lumbering economy, El Nino fear make HSBC downgrade Indian equities to 'underweight'
India remains one of the most over-owned market in Asia and the bank says the potential for more equity outflows has increased because foreign positions look stretched. -
Mar 24, 2015
Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments
The two firms have received nod from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their merger. -
Mar 03, 2015
Sun Pharma to buy GSK's opiates business in Australia
The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment. -
Apr 08, 2014
Dilip Shanghvi: A look at the man behind the mega Sun Pharma-Ranbaxy deal
Shangvi is known as the 'risk-taker, a sharp analyser, and a shrewd businessman' by his industry peers. -
May 31, 2013
Deal Stream: Sun Pharma planning to buy Sweden's Meda for $6 bln?
Array
